Drug Reduction Intervention for Needle Exchange Clients
针交换客户的药物减少干预
基本信息
- 批准号:6800555
- 负责人:
- 金额:$ 39.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-25 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:HIV infectionsadult human (21+)behavior therapyclinical researchcost effectivenessdisease /disorder proneness /riskdrug abuse therapyhuman subjecthuman therapy evaluationinjection /infusioninterviewlongitudinal human studymotivationneedle sharingoutcomes researchplacebossubstance abuse related behavior
项目摘要
DESCRIPTION: (Applicant's Abstract)
Injection drug users are at risk for a variety of problems such as HIV
infection, hepatitis B and C, endocarditis, trauma, legal and work difficulties
and family dysfunction. The objective of this research is to investigate ways
to effectively reduce drug use among needle exchange program users, whose
attendance at such services may signal the beginnings of risk reduction and a
desire to escape drug use. In the past two decades brief interventions have
proven to be promising in reducing substance abuse in a variety of settings.
Recent developments in treatments for substance abuse underscore the primacy of
utilizing motivation-based approaches. However, few studies have examined the
likelihood that using a brief motivation based intervention with drug users
enrolled in needle exchange programs may improve drug use outcomes.
Intensifying brief intervention by adding a booster session might further
enhance efficacy.
The long-term objective of this programmatic body of treatment outcome research
is to provide effective brief interventions for adult substance abusers. The
specific aims of this proposal are to investigate the extent to which a
Motivational Interview with a booster session is effective in reducing drug use
among injection drug users enrolled in needle exchange programs as compared to
an Attention Placebo Control (AQ condition in a 2-group design. Patients will
be followed at 1-and 6 months after the baseline intervention, with
self-reports confirmed by urine screens and reports of family or friends.
Primary outcome variables include total number of drug use days and number of
days in treatment. It is hypothesized that groups receiving MI will show lower
levels of drug using days and more days of substance abuse treatment and that
2) the relationship between MI and the outcome variables will vary as a
function of the patient's degree of readiness to change.
This study will extend previous research by evaluating the use of MI with
individuals who are needle exchange participants. The development of effective
interventions for a population with poor linkage to primary care, an enormous
burden of illness, and high HIV transmission risk should reduce the chronicity
of drug use and enhance days in drug treatment.
描述:(申请人摘要)
注射吸毒者面临多种问题的风险,例如艾滋病毒
感染、乙型和丙型肝炎、心内膜炎、创伤、法律和工作困难
以及家庭功能失调。本研究的目的是探讨方法
有效减少针具交换计划使用者的药物使用,其
参加此类服务可能标志着风险降低的开始和
渴望逃避吸毒。在过去的二十年里,短暂的干预已经
事实证明,它在减少各种环境中的药物滥用方面很有希望。
药物滥用治疗的最新进展强调了药物滥用治疗的首要地位
利用基于动机的方法。然而,很少有研究考察
对吸毒者进行基于动机的简短干预的可能性
参加针头交换计划可能会改善吸毒结果。
通过增加强化课程来强化短暂干预可能会进一步
增强功效。
该治疗结果研究计划机构的长期目标
的目的是为成年药物滥用者提供有效的简短干预措施。这
该提案的具体目标是调查
励志访谈和加强会议可有效减少吸毒
参加针头交换计划的注射吸毒者中
注意安慰剂对照(两组设计中的 AQ 状况。患者将
基线干预后 1 个月和 6 个月进行随访,
通过尿液筛查确认的自我报告以及家人或朋友的报告。
主要结果变量包括吸毒总天数和吸毒次数
治疗中的天数。据推测,接受 MI 的群体的表现会较低
吸毒天数和药物滥用治疗天数的水平
2) MI 和结果变量之间的关系将随着
患者的功能变化的准备程度。
本研究将通过评估 MI 的使用来扩展之前的研究
针头交换参与者的个人。发展有效的
对与初级保健联系较差的人群进行干预措施,需要付出巨大的努力
疾病负担和高艾滋病毒传播风险应减少慢性病
减少药物使用并延长药物治疗天数。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Swift其他文献
Robert Swift的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Swift', 18)}}的其他基金
Crossover Study of an Oral Treatment for Sickle Cell Disease
镰状细胞病口服治疗的交叉研究
- 批准号:
9347994 - 财政年份:2017
- 资助金额:
$ 39.25万 - 项目类别:
Identification of the Antisickling Compounds in SCD-101
SCD-101 中抗镰化化合物的鉴定
- 批准号:
9407759 - 财政年份:2017
- 资助金额:
$ 39.25万 - 项目类别:
Elucidation of Antisickling Molecules in a Botanical with Antisickling Activity
具有抗镰刀活性的植物中抗镰刀分子的阐明
- 批准号:
8589491 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
镰状细胞病植物药临床试验的安全性研究
- 批准号:
9052235 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
First Clinical Trial of an Anti-Sickling Botanical Drug for Sickle Cell Dise
抗镰状细胞病植物药物的首次临床试验
- 批准号:
8529844 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Safety Studies for Clinical Trials of a Botanical Drug for Sickle Cell Disease
镰状细胞病植物药临床试验的安全性研究
- 批准号:
9335417 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别:
Toxicity Studies of Potent Antisickling Agent 5HMF
强效抗镰刀剂5HMF的毒性研究
- 批准号:
7108317 - 财政年份:2006
- 资助金额:
$ 39.25万 - 项目类别:
相似海外基金
Integration of Trusted Adult Supports into the HealthMpowerment App to Improve Black Adolescent and Young Adult PrEP Use
将值得信赖的成人支持整合到 HealthMpowerment 应用程序中,以改善黑人青少年和年轻成人 PrEP 的使用
- 批准号:
10483485 - 财政年份:2022
- 资助金额:
$ 39.25万 - 项目类别:
Integration of Trusted Adult Supports into the HealthMpowerment App to Improve Black Adolescent and Young Adult PrEP Use
将值得信赖的成人支持整合到 HealthMpowerment 应用程序中,以改善黑人青少年和年轻成人 PrEP 的使用
- 批准号:
10610486 - 财政年份:2022
- 资助金额:
$ 39.25万 - 项目类别:
Physician Attitudes toward New Biomedical HIV Prevention Interventions in Youth
医生对青年新的生物医学艾滋病毒预防干预措施的态度
- 批准号:
9335414 - 财政年份:2013
- 资助金额:
$ 39.25万 - 项目类别: